
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| AL(L) | 412 | 89.0% | -3.52 | 36 | 8.7% |
| SLP(L) | 23 | 5.0% | 3.26 | 221 | 53.4% |
| CentralBrain-unspecified | 16 | 3.5% | 2.32 | 80 | 19.3% |
| PLP(L) | 8 | 1.7% | 2.39 | 42 | 10.1% |
| SCL(L) | 1 | 0.2% | 4.39 | 21 | 5.1% |
| SMP(L) | 1 | 0.2% | 3.81 | 14 | 3.4% |
| CA(L) | 1 | 0.2% | -inf | 0 | 0.0% |
| VES(L) | 1 | 0.2% | -inf | 0 | 0.0% |
| LH(L) | 0 | 0.0% | 0.00 | 0 | 0.0% |
| upstream partner | # | NT | conns M_lvPNm37 | % In | CV |
|---|---|---|---|---|---|
| vLN24 (L) | 2 | ACh | 20.5 | 12.5% | 0.8 |
| DL4_adPN (L) | 1 | ACh | 18 | 10.9% | 0.0 |
| ORN_DL2d | 6 | ACh | 18 | 10.9% | 0.6 |
| ORN_VL1 | 8 | ACh | 18 | 10.9% | 0.9 |
| v2LN41 (L) | 2 | unc | 9.5 | 5.8% | 0.3 |
| M_lvPNm35 (L) | 2 | ACh | 5 | 3.0% | 0.2 |
| v2LN41 (R) | 2 | unc | 4 | 2.4% | 0.5 |
| M_l2PNm15 (L) | 1 | ACh | 3.5 | 2.1% | 0.0 |
| HRN_VP4 | 6 | ACh | 3.5 | 2.1% | 0.3 |
| ALIN5 (R) | 1 | GABA | 3 | 1.8% | 0.0 |
| CL063 (L) | 1 | GABA | 3 | 1.8% | 0.0 |
| lLN2P_a (L) | 1 | GABA | 2.5 | 1.5% | 0.0 |
| HRN_VP1d | 3 | ACh | 2.5 | 1.5% | 0.6 |
| v2LN39a (L) | 2 | Glu | 2.5 | 1.5% | 0.2 |
| lLN2R_a (L) | 2 | GABA | 2 | 1.2% | 0.5 |
| ORN_DL1 | 3 | ACh | 2 | 1.2% | 0.4 |
| DL1_adPN (L) | 2 | ACh | 2 | 1.2% | 0.0 |
| vLN26 (L) | 1 | unc | 1.5 | 0.9% | 0.0 |
| LHPV6f3_b (R) | 1 | ACh | 1.5 | 0.9% | 0.0 |
| SLP355 (R) | 1 | ACh | 1.5 | 0.9% | 0.0 |
| ORN_VL2a | 2 | ACh | 1.5 | 0.9% | 0.3 |
| v2LN30 (L) | 1 | unc | 1.5 | 0.9% | 0.0 |
| ORN_DL2v | 2 | ACh | 1.5 | 0.9% | 0.3 |
| VP1l+_lvPN (L) | 2 | ACh | 1.5 | 0.9% | 0.3 |
| CB3417 (L) | 2 | unc | 1.5 | 0.9% | 0.3 |
| M_lPNm11C (L) | 1 | ACh | 1.5 | 0.9% | 0.0 |
| M_lvPNm37 (L) | 2 | ACh | 1.5 | 0.9% | 0.3 |
| M_lPNm11D (L) | 2 | ACh | 1.5 | 0.9% | 0.3 |
| lLN1_bc (L) | 2 | ACh | 1.5 | 0.9% | 0.3 |
| lLN2T_a (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| ORN_DL5 | 1 | ACh | 1 | 0.6% | 0.0 |
| VL1_ilPN (R) | 1 | ACh | 1 | 0.6% | 0.0 |
| VP1d+VP4_l2PN1 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| v2LN42 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| lLN2X04 (L) | 2 | ACh | 1 | 0.6% | 0.0 |
| lLN2X12 (L) | 2 | ACh | 1 | 0.6% | 0.0 |
| M_l2PNm16 (L) | 2 | ACh | 1 | 0.6% | 0.0 |
| lLN2T_e (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| CSD (R) | 1 | 5-HT | 1 | 0.6% | 0.0 |
| il3LN6 (R) | 1 | GABA | 1 | 0.6% | 0.0 |
| lLN2P_b (L) | 2 | GABA | 1 | 0.6% | 0.0 |
| lLN2F_a (L) | 2 | unc | 1 | 0.6% | 0.0 |
| HRN_VP1l | 1 | ACh | 0.5 | 0.3% | 0.0 |
| LHPV6k2 (L) | 1 | Glu | 0.5 | 0.3% | 0.0 |
| ORN_VL2p | 1 | ACh | 0.5 | 0.3% | 0.0 |
| ORN_DP1m | 1 | ACh | 0.5 | 0.3% | 0.0 |
| CB3383 (L) | 1 | ACh | 0.5 | 0.3% | 0.0 |
| SLP109 (L) | 1 | Glu | 0.5 | 0.3% | 0.0 |
| M_lvPNm38 (L) | 1 | ACh | 0.5 | 0.3% | 0.0 |
| M_adPNm8 (L) | 1 | ACh | 0.5 | 0.3% | 0.0 |
| CB3308 (L) | 1 | ACh | 0.5 | 0.3% | 0.0 |
| lLN2P_c (L) | 1 | GABA | 0.5 | 0.3% | 0.0 |
| VP1l+VP3_ilPN (L) | 1 | ACh | 0.5 | 0.3% | 0.0 |
| lLN2X05 (L) | 1 | ACh | 0.5 | 0.3% | 0.0 |
| lLN2T_c (L) | 1 | ACh | 0.5 | 0.3% | 0.0 |
| v2LN31 (L) | 1 | unc | 0.5 | 0.3% | 0.0 |
| DL5_adPN (L) | 1 | ACh | 0.5 | 0.3% | 0.0 |
| DL2d_adPN (L) | 1 | ACh | 0.5 | 0.3% | 0.0 |
| FB9C (L) | 1 | Glu | 0.5 | 0.3% | 0.0 |
| CB1059 (L) | 1 | Glu | 0.5 | 0.3% | 0.0 |
| CB1846 (L) | 1 | Glu | 0.5 | 0.3% | 0.0 |
| v2LN49 (L) | 1 | Glu | 0.5 | 0.3% | 0.0 |
| CB2600 (L) | 1 | Glu | 0.5 | 0.3% | 0.0 |
| v2LN32 (L) | 1 | Glu | 0.5 | 0.3% | 0.0 |
| v2LN46 (L) | 1 | Glu | 0.5 | 0.3% | 0.0 |
| M_vPNml65 (L) | 1 | GABA | 0.5 | 0.3% | 0.0 |
| DN1pB (L) | 1 | Glu | 0.5 | 0.3% | 0.0 |
| D_adPN (L) | 1 | ACh | 0.5 | 0.3% | 0.0 |
| lLN1_a (L) | 1 | ACh | 0.5 | 0.3% | 0.0 |
| lLN8 (R) | 1 | GABA | 0.5 | 0.3% | 0.0 |
| downstream partner | # | NT | conns M_lvPNm37 | % Out | CV |
|---|---|---|---|---|---|
| CB3556 (L) | 4 | ACh | 16.5 | 7.1% | 0.5 |
| SLP316 (L) | 2 | Glu | 15 | 6.5% | 0.1 |
| FB8B (L) | 2 | Glu | 13 | 5.6% | 0.5 |
| CB1326 (L) | 2 | ACh | 8 | 3.4% | 0.4 |
| CB1154 (L) | 4 | Glu | 8 | 3.4% | 0.5 |
| VP1d+VP4_l2PN2 (L) | 1 | ACh | 7.5 | 3.2% | 0.0 |
| CB2970 (L) | 1 | Glu | 7.5 | 3.2% | 0.0 |
| SLP249 (L) | 2 | Glu | 7.5 | 3.2% | 0.5 |
| CL087 (L) | 2 | ACh | 7 | 3.0% | 0.9 |
| SLP373 (L) | 1 | unc | 6.5 | 2.8% | 0.0 |
| SLP364 (L) | 2 | Glu | 6 | 2.6% | 0.8 |
| SLP001 (L) | 1 | Glu | 5.5 | 2.4% | 0.0 |
| SLP363 (L) | 1 | Glu | 5.5 | 2.4% | 0.0 |
| FB1D (L) | 2 | Glu | 5.5 | 2.4% | 0.5 |
| CB0943 (L) | 2 | ACh | 4.5 | 1.9% | 0.8 |
| CB4126 (L) | 1 | GABA | 4.5 | 1.9% | 0.0 |
| lLN2T_d (L) | 2 | unc | 4.5 | 1.9% | 0.1 |
| CB1011 (L) | 1 | Glu | 4 | 1.7% | 0.0 |
| CB3055 (L) | 2 | ACh | 4 | 1.7% | 0.8 |
| SLP322 (L) | 2 | ACh | 4 | 1.7% | 0.2 |
| CB1617 (L) | 1 | Glu | 3.5 | 1.5% | 0.0 |
| LHPV5i1 (L) | 1 | ACh | 3.5 | 1.5% | 0.0 |
| FB1E_b (L) | 1 | Glu | 3.5 | 1.5% | 0.0 |
| SLP266 (L) | 2 | Glu | 3.5 | 1.5% | 0.4 |
| SMP297 (L) | 1 | GABA | 3 | 1.3% | 0.0 |
| CB3081 (L) | 1 | ACh | 3 | 1.3% | 0.0 |
| LHPV4c4 (L) | 1 | Glu | 2.5 | 1.1% | 0.0 |
| PLP080 (L) | 1 | Glu | 2.5 | 1.1% | 0.0 |
| CB3383 (L) | 1 | ACh | 2.5 | 1.1% | 0.0 |
| CB3308 (L) | 1 | ACh | 2.5 | 1.1% | 0.0 |
| M_l2PNm15 (L) | 1 | ACh | 2 | 0.9% | 0.0 |
| CB3173 (L) | 1 | ACh | 2 | 0.9% | 0.0 |
| CB1352 (L) | 1 | Glu | 2 | 0.9% | 0.0 |
| ATL020 (L) | 1 | ACh | 2 | 0.9% | 0.0 |
| DN1pB (L) | 2 | Glu | 2 | 0.9% | 0.5 |
| CB1057 (L) | 1 | Glu | 2 | 0.9% | 0.0 |
| SMP304 (L) | 1 | GABA | 2 | 0.9% | 0.0 |
| CSD (R) | 1 | 5-HT | 2 | 0.9% | 0.0 |
| SLP459 (L) | 1 | Glu | 1.5 | 0.6% | 0.0 |
| CB4022 (L) | 1 | ACh | 1.5 | 0.6% | 0.0 |
| SLP075 (L) | 1 | Glu | 1.5 | 0.6% | 0.0 |
| SLP403 (L) | 2 | unc | 1.5 | 0.6% | 0.3 |
| SLP414 (L) | 2 | Glu | 1.5 | 0.6% | 0.3 |
| SMP305 (L) | 1 | unc | 1.5 | 0.6% | 0.0 |
| M_lvPNm37 (L) | 2 | ACh | 1.5 | 0.6% | 0.3 |
| LHPV4c1_c (L) | 1 | Glu | 1.5 | 0.6% | 0.0 |
| CB2876 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SMP344 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| SLP341_a (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 1 | 0.4% | 0.0 |
| lLN2F_b (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| LHPV6f3_b (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SLP078 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| SLP164 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SLP315 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB2600 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| LHPV6f3_b (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB4158 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| M_lvPNm35 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SLP064 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| SLP368 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB3240 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SLP463 (L) | 2 | unc | 1 | 0.4% | 0.0 |
| lLN1_bc (L) | 2 | ACh | 1 | 0.4% | 0.0 |
| SLP456 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| SMP468 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| v2LN34E (L) | 1 | Glu | 0.5 | 0.2% | 0.0 |
| CB3252 (L) | 1 | Glu | 0.5 | 0.2% | 0.0 |
| DNES3 (L) | 1 | unc | 0.5 | 0.2% | 0.0 |
| LHAV3a1_c (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| VP4+VL1_l2PN (R) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| DL4_adPN (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| VP1d+VP4_l2PN1 (R) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| VL1_ilPN (R) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| VP1d+VP4_l2PN1 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| CB4157 (L) | 1 | Glu | 0.5 | 0.2% | 0.0 |
| CB4122 (L) | 1 | Glu | 0.5 | 0.2% | 0.0 |
| CB1901 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| M_lPNm13 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| CB4123 (L) | 1 | Glu | 0.5 | 0.2% | 0.0 |
| CB4083 (L) | 1 | Glu | 0.5 | 0.2% | 0.0 |
| LHPV4l1 (L) | 1 | Glu | 0.5 | 0.2% | 0.0 |
| lLN2P_b (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| vLN24 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| CSD (L) | 1 | 5-HT | 0.5 | 0.2% | 0.0 |
| lLN2T_a (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| CB2377 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |